Inhibitory mechanism of bromocriptine on catecholamine release evoked by cholinergic stimulation and membrane depolarization from the rat adrenal medulla

Archives of Pharmacal Research

Volumn 25, Issue 4, 2002, Pages 511-521

  Lim, Dong Yoon ^a   Lee, Yong Gyoon ^a   Kim, Il Hwan ^a  

^a Chosun University   (South Korea)

Author keywords

Adrenal medulla; Bromocriptine; Catecholamine release; Dopaminergic D 2 Receptors

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM IODIDE; 1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; ACETYLCHOLINE; APOMORPHINE; BROMOCRIPTINE; CALCIUM CHANNEL STIMULATING AGENT; CATECHOLAMINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; CYCLOPIAZONIC ACID; DOPAMINE RECEPTOR STIMULATING AGENT; INDOLE DERIVATIVE; MUSCARINIC AGENT; NICOTINIC AGENT; POTASSIUM;

ADRENAL MEDULLA; ANIMAL; ARTICLE; DRUG EFFECT; ELECTROPHYSIOLOGY; IN VITRO STUDY; MALE; MEMBRANE; METABOLISM; PERFUSION; RAT; SPRAGUE DAWLEY RAT; STIMULATION;

(4-(M-CHLOROPHENYLCARBAMOYLOXY)-2-BUTYNYL)TRIMETHYLAMMONIUM CHLORIDE; 3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ACETYLCHOLINE; ADRENAL MEDULLA; ANIMALS; APOMORPHINE; BROMOCRIPTINE; CALCIUM CHANNEL AGONISTS; CATECHOLAMINES; CHOLINERGIC AGONISTS; DIMETHYLPHENYLPIPERAZINIUM IODIDE; DOPAMINE AGONISTS; ELECTROPHYSIOLOGY; INDOLES; MALE; MEMBRANES; MUSCARINIC AGONISTS; NICOTINIC AGONISTS; PERFUSION; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; STIMULATION, CHEMICAL;

EID: 0036691538     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02976611     Document Type: Article

References (51)

1. Anton, A.H., and Sayre, D.F., A study of the factors affecting the aluminum oxide trihydroxy indole procedure for the analysis of catecholamines. J. Pharmacol. Exp. Ther., 138, 360-375 (1962).
2. 1 dopamine receptors through an AMP/protein kinase Adependent mechanism. Nature, 348, 239-242 (1990).
3. Artalejo, A.R., Garcia, A.G., Montiel, C., and Sanchez-Garcia, P., A dopaminergic receptor modulates catecholamine release from the cat adrenal gland. J. Physiol., 362, 359-368 (1985).
4. 2 dopamine receptors modulate calcium channel currents and catecholamine secretion in bovine adrenal chromaffin cells. J. Pharmacol. Expt. Ther., 252(2), 586-592 (1990).
5. Bigornia, L., Suozzo, M., Ryan, K.A., Napp, D., and Schneider, A.S., Dopamine receptors on adrenal chromaffin cells modulate calcium uptake and catecholamine release. J. Neurochem., 51, 999-1006 (1988).
6. Blanco, M., Hurtado, N., Jelambi, I., Perez, G., Carrillo, M., Gomez, J., Bravo, C., Gomez, H., Collet, H., and Velasco, M., Dopaminergic influence on cardiovascular responses to exercise stress in hypertensive subjects. Am. J. Ther., 4, 31-33 (1997).
7. Caron, M.G., Beaulieu, M., Raymond, V., Gagne, B., Drouin, J., Lefkowitz, R.J., and Labrie, F., Dopaminergic receptors in the anterior pituitary gland. J. Biol. Chem., 253, 2244-2253 (1978).
8. Challiss, R.A.J., Jones, J.A., Owen, P.J., and Boarder, M.R., Changes in inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate mass accumulations in cultured adrenal chromaffin cells in response to bradykinin and histamine. J. Neurochem., 56, 1083-1086 (1991).
9. 2+ in bovine adrenal chromaffin cells: Distinct nicotinic and muscarinic patterns. FEBS. Lett., 247 , 429-434 (1989).
10. Collet, A.R., and Story, D.F., Is catecholamine release from the rabbit adrenal gland subject to regulation through dopamine receptors or β-adrenoceptors? Clin. Exp. Pharmacol. Physiol., 9, 436 (1982a).
11. 3H-adrenaline from an isolated intact preparation of the rabbit adrenal gland: No evidence for release modulatory α-adrenoceptors. J. Auton. Pharmacol., 2, 25-34 (1982b).
12. 2 receptors inhibits rat striatal adenylate cyclase by a GTPdependent process. Mol. Pharmacol., 29, 113-119 (1986).
13. 5 dopamine receptors. J. Neurochem., 67, 1960-1964 (1996).
14. Damase-Michel, C., Montastruc, J.L., Geelen, G., Saint-Blanquat, G.D., and Tran, M.A., Effect of quinpirole a specific dopamine DA2 receptor agonist on the sympathoadrenal system in dogs. J. Pharmacol. Expt. Ther., 252(2), 770-777 (1990).
15. 1-like dopamine receptors. Clin. Expt. Pharmacol. Physiol., 26(suppl.), S67-S68 (1999).
16. De Vliefer, T.A., Lodder, J.C., Werkman, T.R., and Stoof, J.C., Dopamine receptor stimulation has multiple effects on ionic currents in neuroendocrine cells of the pond snail Lymnaea stagnalis. (Abstr) Neuroscience Lett [Suppl]., 22, S418 (1985).
17. 2+ release in streptolysin O-permeabilized bovine adrenal chromaffin cells. J. Neurochem., 56, 665-670 (1991).
18. Forsberg, E.J., Rojas, E., and Pollard, H.P., Muscarinic receptor enhancement of nicotinic-induced catecholamine secretion may be mediated by phosphoinositide metabolism in bovine adrenal chromaffin cells. J. Biol. Chem., 261, 4915-4920 (1986).
19. Garcia, A.G., Sala, F., Reig, J.A., Viniegra, S., Frias, J., Fonteriz, R., and Gandia, L., Dihydropyridine Bay-K-8644 activates chromaffin cell calcium channels. Nature, 309, 69-71 (1984).
20. 2+ permeability. Biochem. Pharmacol ., 38, 3995-4003 (1989).
21. Gonzales, M.C., Artalejo, A.R., Montiel, C., Hervas, P.P., and Garcia, A.G., Characterization of a dopaminergic receptor that modulates adrenomedullary catecholamine release. J. Neurochem., 47, 382-388 (1986).
22. Huettl, P., Gerhardt, G.A., Browning, M.D., and Masserano, J.M., Effects of dopamine receptor agonists and antagonists on catecholamine release in bovine chromaffin cells. J. Pharmacol. Expt. Ther., 257(2), 567-574 (1991).
23. Kebabian, J. W., and Calne, D. B., Multiple receptors for dopamine. Nature, 277(5692), 93-96 (1979).
24. Kebabian. J. W., Augi, T., van Oene. J. C., Shigematsu. K., and Saavedra, J. M., The dopamine receptor: New perspectives. Trends. Pharmacol. Sci., 7, 96-99 (1986).
25. 2+ and secretion from bovine chromaffin cells. Proc. Natl. Acad .Sci. USA., 86, 9881-9885 (1989).
26. Lim, D.Y., Kim, C.D., and Ahn, K.W., Influence of TMB-8 on secretion of catecholamines from the perfused rat adrenal glands. Arch. Pharm. Res., 15(2), 115-125 (1992).
27. Lim, D.Y., Kim, K. H., Choi, C.H., Yoo, H.J., Choi, D.J., and Lee, E.H., Studies on secretion of catecholamines evoked by metoclopramide of the rat adrenal gland. Korean J. Pharmacol., 25(1), 31-42 (1989).
28. Lim, D.Y., Yoon, J.K., and Moon, B., Interrelationship between dopaminergic receptors and catecholamine secretion from the rat adrenal gland. Korean J. Pharmacol., 30(1), 87-100 (1994).
29. Luchsinger, A., Grilli, M., Forte, P., Morales, E., and Velasco, M., Metoclopramide blocks bromocriptine-induced antihypertensive effect in hypertensive patients. International J. Clin. Pharmacol.Ther., 3, 509-512 (1995).
30. 3H] N-methylspiperone binding. J. Neurochem., 48, 631-635 (1987).
31. 2+ increases in rat lactotroph cells. J. Biol. Chem., 262, 13920-13927 (1987).
32. 2+ influx intro rat pituitary cells. Brain Res., 347, 253-257 (1985).
33. Merritt, J.E., and Brown, B.L., The possible involvement of both calcium and cyclic AMP in the dopaminergic inhibition of prolactin secretion. Life Sci., 35, 707-711 (1984).
34. Montastruc, J.L., Gaillard, G., Rascol, O., Tran, M.A., and Montastruc, P., Effect of apomorphine on adrenal medullary catecholamine levels. Fundam. Clin. Pharmacol., 3(6 ), 665-670 (1989).
35. Montiel, C., Artalejo, A. R., Bermejo, P.M., and Sanchez-Garcia P., A dopaminergic receptor in adrenal medulla as a possible site of action for the droperidol-evoked hypertensive response. Anesthesiology, 65(5), 474-479 (1986).
36. ODowd, B. F., Structures of dopamine receptors. J. Neurochem., 60(3), 804-816 (1993).
37. 3H] spiperone. Biochem. Pharmacol., 36, 3707-3713 (1987).
38. Roquebert, J., Alaoui, K., Moran., and Benito, A., Cardiovascular effects of bromocriptine in rats: role of peripheral adrenergic and dopaminergic receptors. J. Auton. Pharmacol., 10, 85-96 (1990).
39. Schettini, G., Cronin, M.J., and Macleod, R.M., Adenosine 3′, 5′-monophosphate(cAMP) and calcium calmodulin interrelation in the control of prolactin secretion: evidence for dopamine inhibition of cAMP accumulation and prolactin release after calcium mobilization. Endocrinology, 112, 1801-1807 (1983).
40. 2+ channels. Nature, 303, 535-537 (1982).
41. 2+-ATPase of sarcoplasimc reticulum. J. Biol. Chem ., 264, 17816-17823 (1989).
42. Sibley, D. R., and Monsma, F. J., Molecular biology of dopamine receptors. Trends Pharmacol. Sci., 13(2), 61-69 (1992).
43. 2+ stores in cat adrenal chromaffin cells. Brain Res., 571, 154-158 (1992).
44. + currents in guineapig smooth muscle cells. Br. J. Pharmacol., 107, 134-140 (1992).
45. Tallarida, R.J., and Murray, R.B., Manual of pharmacologic calculation with computer programs. 2nd Ed. New York Speringer-Verlag, pp. 131-136 (1987).
46. + channels modulated muscarinic secretion in cat chromaffin cells. J. Physiol., 454, 213-230 (1992).
47. Vallar, L., and Meldolesi, J., Mechanisms of signal transduction at the dopamine D2 receptor. Trends Pharmacol. Sci., 10(2), 74-77(1989).
48. Van Loon, G. R., Sole, M. J., Bain, J., and Ruse, J. L., Effects of bromocriptine on plasma catecholamines in normal men. Neuroendocrinology, 28, 425-434 (1979).
49. Wada, Y., Satoh, K., and Taira, N., Cardiovascular profile of Bay-K-8644, a presumed calcium channel activator in the dog. Naunyn-Schmiedebergs. Arch. Pharmacol., 328, 382-387 (1985).
50. Wakade, A.R., Studies on secretion of catecholamines evoked by acetylcholine or transmural stimulation of the rat adrenal gland. J. Physiol., 313, 463-480 (1981).
51. Ziegler, M.G., Lake, C.R., Williams, A.C., Teychenne, P.F., Shoulson, I., and Steinsland, O., Bromocriptine inhibits norepinephrine release. Clin. Pharmacol. Ther., 25, 137-142 (1979).